Effect of early octreotide administration on the development of esophageal varices in cirrhotic rats

Hepatology Research

Volumn 29, Issue 2, 2004, Pages 104-112

  Ballas, Konstantinos D ^a   Tzioufa Asimakopoulou, Valentine ^a   Marakis, George ^a   Alatsakis, Michael B ^a   Papavasiliou, Athanassios V ^a   Rafailidis, Savvas ^a   Sakadamis, Athanassios K ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Esophageal varices; Liver cirrhosis; Octreotide; Portal hypertension

Indexed keywords

CARBON TETRACHLORIDE; OCTREOTIDE; PHENOBARBITAL; PLACEBO; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ESOPHAGUS VARICES; HEMODYNAMICS; HISTOPATHOLOGY; KIDNEY VEIN; LIVER CIRRHOSIS; MALE; MORPHOMETRICS; NONHUMAN; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; RAT; SUBMUCOSA; VEIN DILATATION; VEIN LIGATION;

EID: 2442707940     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2004.02.016     Document Type: Article

References (28)

1. Lin H.C. Soubrane O. Cailmail S. Lebrec D. Early chronic administration of propranolol reduces the severity of portal hypertension and portal systemic shunting in conscious portal vein stenosed rats J. Hepatol. 13 1991 213-219
2. Sarin S.K. Groszmann R.J. Mosca P.G. Propranolol ameliorates the develpment of portal systemic shunting in a chronic murine schistosomiasis model of portal hypertension J. Clin. Invest. 87 1991 1032-1036
3. Sarin S.K. Stadeker M. Groszmann R.J. Propranolol prevents the development of portal systemic shunting in chronic murine schistosomiasis Gastroenterology 96 1989 A654
4. Ruthardt F.W. Stauber R.E. Kuhlen R. Ban Thiel D.H. Chronic beta blockade reduces portal systemic shunting in portal hypertensive rats Gastroenterology 98 1990 A199
5. Lin H. Soubrane O. Lebrec D. Prevention of portal hypertension and portosystemic shunts by early chronic administration of clonidine in conscious portal vein stenosed rats Hepatology 14 1991 325-330
6. Tyden G. Samnegaard H. Thulin L. Circulatory effects of somatostatin in anaesthetized man Acta Chir. Scand. 145 1979 443-446
7. Jenkins S.A. Baxter J.N. Shields R. The effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the cirrhotic rat Br. J. Surg. 72 1985 864-867
8. Jenkins S.A. Baxter J.N. Corbett W.A. Effects of somatostatin analogue SMS 201-995 on hepatic haemodynamics in the pig and on intravariceal pressure in man Br. J. Surg. 72 1985 1009-1012
9. Jenkins S.A. Baxter J.N. Corbett W.A. A prospective randomized controlled clinical trial comparing somatostain and vasopressin in controlling acute variceal haemorrhage Br. Med. J. 290 1985 275-278
10. Jenkins S.A. Baxter J.N. Snowden S. The effects of somatostatin and SMS 201-995 on hepatic and systemic haemodynamics in patients with cirrhosis and portal hypertension Fibrinolysis 2 1988 48-50
11. Eriksson L.S. Brundin T. Soderlund C. Haemodynamic effects of a long acting somatostatin analogue in patients with liver cirrhosis Scand. J. Gastroenterol. 22 1987 919-925
12. Jenkins S.A. Devitt P. Day D.W.D. Baxter J.N.B. Shields R. The effect of somatostatin on hepatic haemodynamics in the cirrhotic rat Digestion 333 1986 126-134
13. Bosch J. Kravetz D. Rodes J. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin Gastroenterology 80 1981 518-525
14. Sakadamis A.K. Ballas K.D. Tzioufa V. Alatsakis M. A rat model of liver cirrhosis and esophageal varices Res. Exp. Med. 200 2001 137-154
15. Proctor E. Chatamra K. High yield micronodular cirrhosis in the rat Gastroenterology 83 1982 1183-1190
16. Proctor E. Chatamra K. Standardized micronodular cirrhosis in the rat Eur. Surg. Res. 16 1984 182-186
17. Marbach P. Briner U. Lemaire M. Schwitzer A. Terasaki T. From somatostatin to sandostatin: pharmacodynamics and pharmacokinetics Digestion 54 suppl. 1993 9-13
18. Debaene B. Goldfarb G. Braillon A. Effects of ketamine, halothane, enflurane and isoflurane on systemic and splanchnic hemodynamics in normovolemic and hypovolemic cirrhotic rats Anesthesiology 73 1990 118-124
19. Zimpfer M. Manders W.T. Barger A.C. Vatner S.F. Pentobarbital alters compensatory neural and humoral mechanisms in response to hemorrhage Am. J. Physiol. 243 1982 713-721
20. Lee S.S. Hadengue A. Girod C. Lebrec D. Discrepant responses to betaxolol in conscious and anaesthetized portal hypertensive rats Hepatology 3 1986 S139
21. Sonnnenburg G.E. Keller U. Perruchud A. Effects of somatostatin on splanchnic haemodynamics Gastroenterology 80 1981 5226-5232
22. Merkel C. Gatta A. Zuin R. Effect of somatostatin on splanchnic haemodynamics in patients with liver cirrhosis and portal hypertension Digestion 32 1985 92-98
23. + retention in portal hypertensive rats Gastroenterology 1042 1993 575-579
24. Lin H. Yang M.C. Hou M. et al. Effects of long-term administration of octreotide in portal vein-stenosed rats Hepatology 23 1996 537-543
25. Fort J. Oberti F. Pilette C. et al. Antifibrotic and hemodynamic effects of the early and chronic administration of octreotide in two models of liver fibrosis in rats Hepatology 28 1998 1525-1531
26. Lee F.Y. Wang S.S. Tsai Y.T. et al. Hemodynamic studies and esophageal morphometric analyses in portal hypertensive rats with adrenal vein ligation Scand. J. Gastroenterol. 32 1997 725-730
27. Tanoue E. Kitano S. Sugimachi K. A rat model of esophageal varices Hepatology 13 1991 353-358
28. Lee F.Y. Colombato L.A. Albillos A. Administration of N-omega-nitro-l-arginine ameliorates portal-systemic shunting in portal-hypertensive rats Gastroenterology 105 1993 1464-1470